108 related articles for article (PubMed ID: 11472213)
1. Structure-activity studies of ground- and transition-state analogue inhibitors of cyclophilin.
Wang HC; Kim K; Bakhtiar R; Germanas JP
J Med Chem; 2001 Aug; 44(16):2593-600. PubMed ID: 11472213
[TBL] [Abstract][Full Text] [Related]
2. Peptidyl-prolyl isomerase inhibitors.
Wang XJ; Etzkorn FA
Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel Cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies.
Grädler U; Schwarz D; Blaesse M; Leuthner B; Johnson TL; Bernard F; Jiang X; Marx A; Gilardone M; Lemoine H; Roche D; Jorand-Lebrun C
Bioorg Med Chem Lett; 2019 Dec; 29(23):126717. PubMed ID: 31635932
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of Glypsi(PO(2)R-N)Pro-containing pseudopeptides as novel inhibitors of the human cyclophilin hCyp-18.
Demange L; Moutiez M; Dugave C
J Med Chem; 2002 Aug; 45(18):3928-33. PubMed ID: 12190314
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of cis-trans isomerization of prolyl peptides by cyclophilin.
Hur S; Bruice TC
J Am Chem Soc; 2002 Jun; 124(25):7303-13. PubMed ID: 12071739
[TBL] [Abstract][Full Text] [Related]
6. Investigations of cyclophilin interactions with oligopeptides containing proline by affinity capillary electrophoresis.
Kiessig S; Thunecke F
J Chromatogr A; 2002 Dec; 982(2):275-83. PubMed ID: 12489884
[TBL] [Abstract][Full Text] [Related]
7. p53 Is Potentially Regulated by Cyclophilin D in the Triple-Proline Loop of the DNA Binding Domain.
Kumutima J; Yao XQ; Hamelberg D
Biochemistry; 2021 Mar; 60(8):597-606. PubMed ID: 33591178
[TBL] [Abstract][Full Text] [Related]
8. Dynamic combinatorial self-assembly of cyclophilin hCyp-18 ligands through oxorhenium coordination.
Clavaud C; Le Gal J; Thai R; Moutiez M; Dugave C
Chembiochem; 2008 Jul; 9(11):1823-9. PubMed ID: 18604836
[TBL] [Abstract][Full Text] [Related]
9. From chemical tools to clinical medicines: nonimmunosuppressive cyclophilin inhibitors derived from the cyclosporin and sanglifehrin scaffolds.
Sweeney ZK; Fu J; Wiedmann B
J Med Chem; 2014 Sep; 57(17):7145-59. PubMed ID: 24831536
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of peptidyl-prolyl cis/trans isomerase activity by substrate analog structures: thioxo tetrapeptide-4-nitroanilides.
Schutkowski M; Wöllner S; Fischer G
Biochemistry; 1995 Oct; 34(40):13016-26. PubMed ID: 7548060
[TBL] [Abstract][Full Text] [Related]
11. Oligopeptide cyclophilin inhibitors: a reassessment.
Schumann M; Jahreis G; Kahlert V; Lücke C; Fischer G
Eur J Med Chem; 2011 Nov; 46(11):5556-61. PubMed ID: 21963115
[TBL] [Abstract][Full Text] [Related]
12. Peptidyl prolyl cis/trans-isomerases: comparative reactivities of cyclophilins, FK506-binding proteins, and parvulins with fluorinated oligopeptide and protein substrates.
Golbik R; Yu C; Weyher-Stingl E; Huber R; Moroder L; Budisa N; Schiene-Fischer C
Biochemistry; 2005 Dec; 44(49):16026-34. PubMed ID: 16331962
[TBL] [Abstract][Full Text] [Related]
13. A stereoselective cyclization strategy for the preparation of γ-lactams and their use in the synthesis of α-methyl-β-proline.
Banerjee S; Smith J; Smith J; Faulkner C; Masterson DS
J Org Chem; 2012 Dec; 77(23):10925-30. PubMed ID: 23126540
[TBL] [Abstract][Full Text] [Related]
14. Glycosidase inhibition by ring-modified castanospermine analogues: tackling enzyme selectivity by inhibitor tailoring.
Aguilar-Moncayo M; Gloster TM; Turkenburg JP; García-Moreno MI; Ortiz Mellet C; Davies GJ; García Fernández JM
Org Biomol Chem; 2009 Jul; 7(13):2738-47. PubMed ID: 19532990
[TBL] [Abstract][Full Text] [Related]
15. Cyclophilin inhibition as potential therapy for liver diseases.
Naoumov NV
J Hepatol; 2014 Nov; 61(5):1166-74. PubMed ID: 25048953
[TBL] [Abstract][Full Text] [Related]
16. Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds.
Dunyak BM; Gestwicki JE
J Med Chem; 2016 Nov; 59(21):9622-9644. PubMed ID: 27409354
[TBL] [Abstract][Full Text] [Related]
17. Computational insight into small molecule inhibition of cyclophilins.
Sambasivarao SV; Acevedo O
J Chem Inf Model; 2011 Feb; 51(2):475-82. PubMed ID: 21194235
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and peptidyl-prolyl isomerase inhibitory activity of quinoxalines as ligands of cyclophilin A.
Wang F; Chen J; Liu X; Shen X; He X; Jiang H; Bai D
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):372-6. PubMed ID: 16508195
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of B-ring analogues of (-)-rhazinilam.
Décor A; Monse B; Martin MT; Chiaroni A; Thoret S; Guénard D; Guéritte F; Baudoin O
Bioorg Med Chem; 2006 Apr; 14(7):2314-32. PubMed ID: 16314101
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial self-assembly of cyclophilin hCyp-18 ligands through rhenium coordination.
Clavaud C; Heckenroth M; Stricane C; Lelait MA; Ménez A; Dugave C
Chembiochem; 2006 Sep; 7(9):1352-5. PubMed ID: 16835860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
